Skip to main content
. 2022 Sep 2;17:225. doi: 10.1186/s13019-022-01949-w

Table 1.

Baseline Characteristics of the Patients (n = 537)

Age (years) 60.6 ± 8.33
Male (%) 428 (79.7)
Hypertension (%) 337 (62.8)
Hyperlipidemia (%) 426 (81.6)
Diabetes (%) 203(37.8)
Smoking (%) 235 (54.9)
Arrhythmia (%) 19 (3.5)
LVEF (%) 60.20 ± 7.27
BMI (kg/m2) 25.94 ± 3.22
HGB (g/L) 134.59 ± 17.40
PLT count (× 109/L) 214.96 ± 58.15
PCT (%) 0.23 ± 0.06
PT (sec) 13.21 ± 1.75
APTT (sec) 36.85 ± 7.35
FIB (g/L) 3.55 ± 0.83
D-dimer (μg/ml) 0.27 (0.21, 0.42)
FDP (μg/ml) 2.5 (2.5, 2.5)
Aspirin (%) 204 (3.8)
Ticagrelor (%) 24 (4.5)
Tranexamic acid (%) 354 (69.4)
CRP (mg/L) 1.52 (0.70, 3.11)
Postoperative bleeding (mL/24 h) 430 (320, 580)

LVEF left ventricular ejection fraction, BMI body mass index, HGB hemoglobin, PLT platelet, PCT plateletcrit, PT prothrombin time, APTT activated partial thromboplastin time, FIB fibrinogen, FDP fibrinogen degradation product, CRP C-reactive protein